Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.

The prescription device is a wearable belt that includes a motor designed to transmit low amplitude, high frequency vibration to the spine and hips.

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of hypertension in adults, to lower blood pressure.

The approach could mean no COVID boosters will be approved in time for next winter’s respiratory disease season, Makary has warned in earlier interviews.

The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

HealthDay News — More US children have died from the flu this season than in any year since the 2009 swine flu pandemic, according to a new federal report.

HealthDay News — North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge, the Associated Press is reporting.